VISENTIN, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.091
AS - Asia 2.447
EU - Europa 2.147
AF - Africa 643
SA - Sud America 562
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 32
Totale 10.987
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.780
SG - Singapore 889
IT - Italia 553
CN - Cina 385
BR - Brasile 333
HK - Hong Kong 281
DE - Germania 199
PL - Polonia 149
VN - Vietnam 147
FI - Finlandia 139
SE - Svezia 134
FR - Francia 129
IN - India 86
NL - Olanda 86
RU - Federazione Russa 82
GB - Regno Unito 69
KR - Corea 68
CI - Costa d'Avorio 54
ES - Italia 49
AR - Argentina 42
TR - Turchia 39
IE - Irlanda 34
CH - Svizzera 33
AT - Austria 31
IQ - Iraq 28
EC - Ecuador 27
NO - Norvegia 27
CA - Canada 26
ID - Indonesia 26
UA - Ucraina 26
CL - Cile 25
BA - Bosnia-Erzegovina 24
PR - Porto Rico 24
AZ - Azerbaigian 23
CO - Colombia 23
CV - Capo Verde 23
CZ - Repubblica Ceca 23
EG - Egitto 23
ET - Etiopia 23
PT - Portogallo 23
RS - Serbia 23
AL - Albania 22
IL - Israele 22
MX - Messico 22
IR - Iran 21
KZ - Kazakistan 21
MK - Macedonia 21
PE - Perù 21
RO - Romania 21
TJ - Tagikistan 21
TN - Tunisia 21
VE - Venezuela 21
EE - Estonia 20
IS - Islanda 20
LV - Lettonia 20
MY - Malesia 20
PY - Paraguay 20
ZA - Sudafrica 20
CY - Cipro 19
GF - Guiana Francese 19
JP - Giappone 19
ME - Montenegro 19
RE - Reunion 19
UG - Uganda 19
UY - Uruguay 19
UZ - Uzbekistan 19
YE - Yemen 19
AF - Afghanistan, Repubblica islamica di 18
CD - Congo 18
KE - Kenya 18
LB - Libano 18
PH - Filippine 18
BB - Barbados 17
BE - Belgio 17
BF - Burkina Faso 17
BS - Bahamas 17
CW - ???statistics.table.value.countryCode.CW??? 17
DO - Repubblica Dominicana 17
GR - Grecia 17
JO - Giordania 17
LA - Repubblica Popolare Democratica del Laos 17
NE - Niger 17
NI - Nicaragua 17
PK - Pakistan 17
SO - Somalia 17
AE - Emirati Arabi Uniti 16
BG - Bulgaria 16
CR - Costa Rica 16
GH - Ghana 16
KH - Cambogia 16
LY - Libia 16
MR - Mauritania 16
NG - Nigeria 16
NP - Nepal 16
SN - Senegal 16
TT - Trinidad e Tobago 16
TZ - Tanzania 16
DK - Danimarca 15
DZ - Algeria 15
GN - Guinea 15
Totale 10.281
Salva come PNG Salva come JPEG
Città #
Fairfield 575
Singapore 540
Chandler 421
Ashburn 405
Woodbridge 351
Houston 323
Ann Arbor 292
Hong Kong 269
Seattle 246
Cambridge 205
Wilmington 199
Boardman 152
Beijing 141
Padova 138
Santa Clara 134
Bytom 127
Medford 76
Princeton 76
Helsinki 75
Munich 71
San Diego 65
Des Moines 63
Roxbury 62
Abidjan 52
Ho Chi Minh City 41
Los Angeles 38
Dong Ket 36
Nanjing 36
New York 36
Rome 35
São Paulo 34
Milan 32
Hefei 29
Pohang 28
Chicago 25
Dublin 25
Turku 23
Baku 22
Hanoi 22
Nuremberg 22
Dushanbe 20
Praia 20
Kampala 19
Tashkent 19
Modena 18
Montevideo 18
New Delhi 18
Addis Ababa 17
Guangzhou 17
Managua 17
Nairobi 17
Nassau 17
Shenyang 17
Amman 16
Bridgetown 16
Dakar 16
Reykjavik 16
Buffalo 15
Dar es Salaam 15
Nouakchott 15
Podgorica 15
Riga 15
Seoul 15
Tirana 15
Cayenne 14
Council Bluffs 14
Kinshasa 14
London 14
Phnom Penh 14
Tallinn 14
Vientiane 14
Willemstad 14
Bagnolet 13
Bamako 13
Castries 13
Conakry 13
Luanda 13
Panama City 13
Redondo Beach 13
Ulan Bator 13
Vienna 13
Zurich 13
Accra 12
Frankfurt am Main 12
Limassol 12
Lusaka 12
Niamey 12
Ouagadougou 12
Redwood City 12
Sanaa 12
Ulsan 12
Warsaw 12
Yerevan 12
Antananarivo 11
Bishkek 11
Cotonou 11
Dili 11
Gaborone 11
Guayaquil 11
Kigali 11
Totale 6.396
Salva come PNG Salva come JPEG
Nome #
In silico testing of artificial pancreas and new type 1 diabetes treatments: model development and assessment 305
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 219
Smart Insulin Therapy Initiation In Insulin-Naive Subjects With Type 2 Diabetes Using Machine Learning 215
Randomized summer camp crossover trial in 5-to 9-year-old children: Outpatient wearable artificial pancreas is feasible and safe 199
A Model of Acetaminophen Pharmacokinetics and its Effect on Continuous Glucose Monitoring Sensor Measurements 195
Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus 194
Parental evaluation of a telemonitoring service for children with Type 1 Diabetes 189
Multinight "Bedside" closed-loop control for patients with type 1 diabetes 187
Circadian variability of insulin sensitivity: Physiological input for in silico artificial pancreas 182
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes 182
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions 176
Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes 174
Smart Titration of Long-Acting Insulin in Insulin-Naïve Type 2 Diabetic Subjects 172
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. 165
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 164
Effects of the Novel Dual GLP-1R/GCGR Agonist SAR425899 on Postprandial Glucose Metabolism in Overweight/Obese Subjects with Type 2 Diabetes 157
The Padova Type 2 Diabetes Simulator from Triple-Tracer Single-Meal Studies: In Silico Trials Also Possible in Rare but Not-So-Rare Individuals 156
Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations 155
Closing the Loop 150
The University of Virginia/Padova Type 1 Diabetes Simulator Matches the Glucose Traces of a Clinical Trial 148
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator ∗ 145
Hepatic insulin sensitivity in healthy and prediabetic subjects: From a dual- to a single-tracer oral minimal model 144
Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids 144
One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator 141
First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas 140
Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide 139
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes 137
Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator 134
Il pancreas artificiale in età  pediatrica: Prima esperienza Italiana 129
Multicenter Outpatient Wearable Artificial Pancreas (AP) Study: Improved Safety and Efficacy of Glycemic Control 128
A Hybrid Clustering Prediction for Type 1 Diabetes Aid: Towards Decision Support Systems Based upon Scenario Profile Analysis 127
Randomized controlled trial of a MUFA or fiber-rich diet on hepatic fat in prediabetes 121
Incorporating long-acting insulin glargine into the UVA/Padova type 1 diabetes simulator for in silico testing of MDI therapies 121
Modeling Inter-Day Variability of Insulin Sensitivity in Type 1 Diabetic Subjects from 1 Month Outpatient Artificial Pancreas Data 120
Effects of the novel dual GLP-1R/GCGR agonist SAR425899 on postprandial glucose metabolism in overweight/obese subjects with type 2 diabetes 119
MULTI-CENTER RANDOMIZED CROSS-OVER ITALIAN PEDIATRIC SUMMER CAMP: AP VS SAP IN 5-9 YEAR OLD CHILDREN 116
PREDIABETES AND TYPE 2 DIABETES SIMULATOR: IN SILICO TESTING OF NEW DRUGS. DIABETES TECHNOLOGY & THERAPEUTICS 115
Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models 110
The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day 110
In silico head-to-head comparison of insulin glargine 300 U/mL and insulin degludec 100 U/mL in type 1 diabetes 110
Model Assessment of Doxorubicin Pharmacokinetics in Multiple Myeloma 109
Intra-day Variability of Glucose Absorption and Insulin Sensitivity: Assessment from AP@home Clinical Trial Data 108
Physiological models for artificial pancreas development 107
Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study 107
Reduction of Hyper- and Hypoglycemia during Two Months with a Wearable Artificial Pancreas from Dinner to Breakfast in Patients with Type 1 Diabetes 106
PERCEIVED UTILITY OF A REMOTE MONITORING SYSTEM FOR PEDIATRIC SUBJECTS AFFECTED BY TYPE 1 DIABETES IN PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) SUMMER CAMP 106
Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator 105
SMART INSULIN THERAPY INITIATION IMPROVES GLUCOSE CONTROL IN INSULIN‐NAÏVE SUBJECTS WITH TYPE 2 DIABETES 104
Towards a Run-to-Run Adaptive Artificial Pancreas: In Silico Results 104
Dual glucagon-like peptide-1 receptor/glucagon receptor agonist SAR425899 improves beta-cell function in type 2 diabetes 104
Model-based estimate of exercise effect on glucose utilization in subjects with and without type 1 diabetes: validation against gold standard data. 104
Exercise effect on endogenous glucose production in type 1 diabetes: a modeling analysis. 104
null 104
Glucose Controlin Type 2 Diabetes: In Silico Study of Sub-Optimal Adherence to Insulin Therapy 101
INCORPORATION OF INTRA-DAY VARIABILITY INTO THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR 100
1744-P: Hepatic and Disposal Insulin Sensitivity with Single Tracer Method: Use of Naturally Abundant 13C-Polysaccharide 100
Incorporating Nonlinear Response to Hypoglycemia into the Type 1 Diabetes Simulator 98
A Bayesian Method for the Identification of the Glucose-Insulin Model in Type 1 Diabetes 98
In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support 98
Modeling Doxorubicin Treatment Effect in Multiple Myeloma 97
Modeling Pharmacokinetics of Doxorubicin in Multiple Myeloma Cells 97
Smart Algorithms for Efficient Insulin Therapy Initiation in Individuals With Type 2 Diabetes: An in Silico Study 96
Trial in silico di tecnologie per il diabete: Pancreas artificiale, molecole di insulina e sensori di glucosio 96
THE SOCIAL ACCEPTANCE OF FUTURE ARTIFICIAL PANCREAS TECHNOLOGY: PARENTS' PERCEPTIONS OF PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) 95
Clinical Assessment of the Type 1 Diabetes Simulator. 91
A PK/PD Simulation Model for Supporting Doxorubicin Therapy in Multiple Myeloma 90
Cloning a Day of T1DM Individual Subjects from the FDA-accepted Simulator by a Bayesian Approach 90
IP-IP PADOVA SIMULATOR: INTRAPERITONEAL INSULIN DELIVERY AND GLUCOSE SENSING 89
A Novel Method for Generation of In Silico Subjects with Type 2 Diabetes 88
Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance 86
Editorial: Recent Advances in Computer Simulation for Diabetes Treatment and Care 85
A software interface for in silico testing of type 2 diabetes treatments 85
Cloning type 1 diabetic subjects with the UVA/Padova simulator from insulin pump infusion and plasma glucose 85
1856-P: Hepatic Insulin Clearance Is Not Driven by Liver Fat but by Systemic Inflammation: A Mendelian Randomization Study 85
IN SILICO HEAD-TO-HEAD COMPARISON OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC IN TYPE 1 DIABETES 84
SUPPORT VECTOR REGRESSION FOR MID-TERM NOCTURNAL GLUCOSE PREDICTION FROM CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY INFORMATION 83
Incorporation of Models of CGM Sensor Error and Faults Affecting CGM Sensors in the UVA/Padova Type-1 Diabetic Simulator: Assessment on Clinical Data 80
Effects of Nutritional Intervention on Hepatic Fat and Hepatic Insulin Sensitivity in Prediabetes. 76
Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting 75
Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery 75
Modeling Subcutaneous Absorption of U100 and U300 Insulin Glargine in Type 1 Diabetes 73
Short- and Long-Term Effects on Glucose Control of Nonadherence to Insulin Therapy in People With Type 2 Diabetes An In Silico Study 72
1426-P: Increased Insulin Secretion and Glucose Effectiveness Result in Improved Glucose Tolerance in Obese Subjects Two Months after Gastric Bypass and Sleeve 72
The Type 2 Diabetes Simulator: in Silico Testing of Drugs 68
INCORPORATION OF AFREZZA (R) INTO THE TYPE 2 DIABETES SIMULATOR 68
In Silico Optimization of Long-Acting Insulin Injection Time in Subjects With Type 1 Diabetes 66
Modeling the Effect of Liraglutide in T2DM with the T2DM Simulator: a Paradigm for In-Silico Trials 63
RESIDUAL B-CELL FUNCTION IN SUBJECTS WITH TYPE 2 DIABETES PROTECTS FROM NON-ADHERENCE TO INSULIN THERAPY VERSUS SUBJECTS WITH TYPE 1 DIABETES 61
IMPROVEMENT OF THE CHILDREN POPULATION INCLUDED INTO THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR 61
Generating Digital Clones with the UVA/Padova T1D Simulator Identified on CGM and Pump Profiles via a Bayesian Approach 60
TYPE 2 DIABETES SIMULATOR FOR TESTING BASAL INSULIN THERAPY IN INSULIN-NAIVE PATIENTS 59
Doxorubicin PK/PD modeling in multiple myeloma: towards in silico trials 58
INCORPORATION OF THE SENSOR-AUGMENTED INSULIN-PUMP THERAPY INTO THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR 57
Mid-Term Blood Glucose Prediction: A Hybrid Approach Using Grammatical Evolution and Physiological Models 56
The UVA/Padova Type 1 Diabetes Simulator for Optimizing the Dosing Regimen of Inhaled Insulin 54
PERSONALIZED INSULIN BOLUS THERAPY INITIATION IN SUBJECTS WITH TYPE 2 DIABETES 53
The University of Virginia/Padova Type 1 Diabetes Simulator Goes Single Day 53
Variability of carbohydrate estimation skills in adults with type 1 diabetes 46
IMPACT OF CARBOHYDRATE COUNTING ERROR ON GLUCOSE CONTROL DURING INSULIN THERAPY IN TYPE 2 DIABETES 37
Totale 11.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.381
article - articoli 16.818
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 431
Totale 51.630
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021621 0 0 0 0 28 46 18 40 101 97 163 128
2021/20221.002 15 133 100 53 64 96 44 115 62 19 57 244
2022/2023916 157 69 32 97 157 100 8 53 132 33 56 22
2023/2024698 45 110 92 60 45 40 52 45 22 78 57 52
2024/20252.374 36 209 87 93 291 63 88 217 229 86 411 564
2025/20263.524 316 747 1.093 1.242 126 0 0 0 0 0 0 0
Totale 11.166